Skip to content

Investigating the effect of Melissa officinalis capsule on the sexual function of Menopause women

Investigating the effect of Melissa officinalis capsule on the sexual function of Menopause women

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230831059313N1
Enrollment
100
Registered
2023-11-02
Start date
2023-10-22
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual function of Menopause women.

Interventions

Intervention 1: Intervention group: In this research, the intervention group consumes Melissa capsules. These capsules contain 500 mg of Melissa plant extract powder. These capsules are prepared in th

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Be Iranian. At least be literate in reading and writing. At least one year has passed since their menopause. Have a married life with her husband. Not willing or required to use hormone replacement therapy. According to Miss Menopause don't use any chemical or herbal medicine to treat your problem. have sexual activity. Do not use herbal teas while taking medicines.

Exclusion criteria

Exclusion criteria: Have speech, hearing or mental disorders that prevent communication with the researcher. Have undergone hysterectomy and ovariectomy, cystocele and rectocele, and mastectomy. Have a history of known chronic diseases such as high blood pressure, diabetes, asthma, weakening the immune system, etc. Her husband of a menopausal woman have sexual problems. Menopausal women and their husbands are known to have mental illness. Addicted to smoking or drugs. A special event or incident that constitutes a crisis in their life, such as the death of a loved one, incurable illness in family members, change of residence, loss of job has occurred since 6 months ago. Have a history of allergy to medicinal plants. Have a history of endometrial cancer and other estrogen-related cancers in first-degree relatives. Have a history of gluten sensitivity.

Design outcomes

Primary

MeasureTime frame
Sexual function score in female sexual function index questionnaire. Timepoint: At the beginning of the study (before the start of the intervention) and immediately after the end of the intervention and one month after the end of the intervention. Method of measurement: Female Sexual Function Index Questionnaire.

Secondary

MeasureTime frame
Sexual satisfaction score. Timepoint: Before the start of the intervention, immediately after the end of the intervention and one month after the end of the intervention. Method of measurement: ?Female sexual Function Index Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamide Ahmadi

Shahid Beheshti University of Medical Sciences

hamide.ahmadi1990@gmail.com+98 21 8820 2518

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026